Poots 2 , Esther Oliva 3 , Tatyana Ionova 4 , Samantha Nier 5 1 University of Hertfordshire, Hatfield, UK, 2 Picker Institute Europe, Oxford, UK, 3 London North West University Healthcare NHS Trust, London, UK, 4 Saint Petersburg State University Hospital, St Petersburg, Russia, 5 Acute Leukaemia Advocates Network (ALAN), Bone, Switzerland Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :203.5 Aims Leukaemia is a blood cancer that impacts survival and patients quality of life (QoL)
Thus, it prevents the release of arachidonic acid and its conversion to prostaglandins (PGs) (111)
Microdosing chart (3.0 mL reconstitution) At microdoses, the 28-day rule becomes the limiting factor, not vial content
Patient input is key